But it must be used correctly, under medical supervision, Dr Mohan said
Presence of contraindications: According to the company's disclosures, individuals with mood disorders, liver or kidney disease, or those who are pregnant or breastfeeding should avoid use
doi: 10.3389/fcimb.2021.630812 Received 18 November 2020 Accepted 05 February 2021 Published 12 March 2021 Volume 11 - 2021 Edited by Justin Boddey, Walter and Eliza Hall Institute of Medical Research, Australia Reviewed by Sandra Duffy, Griffith University, Australia
Mounjaro also received NICE approval for weight management in 2024, giving NHS services another option
The recommended schedule of dosing is at night to mimic the effects of natural growth hormone release